Device, system and method for functional imaging of episcleral vessels

US10993611B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10993611-B2
Application numberUS-201615044833-A
CountryUS
Kind codeB2
Filing dateFeb 16, 2016
Priority dateFeb 13, 2015
Publication dateMay 4, 2021
Grant dateMay 4, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and systems for assessing regional variations in aqueous outflow vessels of the eye and for optimizing locations within the eye stent implantation or other surgical procedures intended to increase aqueous outflow and reduce intraocular pressure.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for identifying one or more target treatment areas in an eye of a living subject for subsequent performance of a glaucoma surgical treatment, said method comprising: obtaining or providing an imaging probe system which comprises a laser microendoscope having an intraocular tip, a processor and a feedback device; introducing a liquid contrast agent into the eye such that the liquid contrast agent flows through episcleral aqueous outflow vessels; positioning the intraocular tip of the laser microendoscope in contact with the eye; using the laser microendoscope to image the episcleral aqueous outflow vessels within a plurality of regions of interest as those episcleral aqueous outflow vessels are perfused with the liquid contrast agent; causing image data to be transmitted from the laser microendoscope to the processor; causing the processor to quantify flow of the liquid contrast agent through the episcleral aqueous outflow vessels within each of the plurality of regions of interest; causing the feedback device to indicate differences in flow of the liquid contrast agent through the plurality of regions of interest; and using the differences in flow indicated by said feedback device to identify said one or more target treatment areas for subsequent performance of said glaucoma surgical treatment on the basis of the differences in flow of the liquid contrast agent through the plurality of regions of interest indicated by the feedback device, wherein the laser microendoscope emits, from the intraocular tip, laser energy capable of penetrating through scleral tissue to a penetration depth of 30 microns, wherein the processor is configured to apply a vessel segmentation algorithm to the image data obtained by the laser microendoscope from the plurality of regions of interest of the eye and to quantify flow of liquid contrast agent through episcleral aqueous outflow vessels located within each of the plurality of regions of interest, wherein the feedback device is configured to indicate the differences in flow of the liquid contrast agent through the episcleral aqueous outflow vessels within each of the plurality of region of interest, and wherein said glaucoma surgical treatment comprises at least one of i) ablating or forming an opening in trabecular meshwork tissue and ii) implanting a stent or aqueous drainage facilitating device to facilitate aqueous drainage from the eye. 2. The method of claim 1 , wherein the step of using the laser microendoscope to image the episcleral aqueous outflow vessels within said plurality of regions of interest as those episcleral aqueous outflow vessels are perfused with the liquid contrast agent comprises moving the laser microendoscope so as to acquire images at 15 degree intervals along a limbus of the eye. 3. The method of claim 1 , wherein the liquid contrast agent fluoresces. 4. The method of claim 3 , wherein the liquid contrast agent comprises fluorescein. 5. The method of claim 1 , wherein the liquid contrast agent comprises indocyanine green. 6. The method of claim 1 , wherein the microendoscope is positioned substantially 1 mm behind a limbus of the eye. 7. The method of claim 1 , wherein the step of positioning the intraocular tip of the laser microendoscope in contact with the eye comprises forming a flap incision in the eye and positioning the intraocular tip of the laser microendoscope within the flap incision. 8. The method of claim 1 , wherein the step of using the laser microendoscope to image the episcleral aqueous outflow vessels within said plurality of regions of interest as those episcleral aqueous outflow vessels are perfused with the liquid contrast agent is performed about 7 minutes after the step of introducing the liquid contrast agent into the eye such that the liquid contrast agent will outflow through the episcleral aqueous outflow vessels of the eye. 9. The method of claim 1 , wherein the feedback device comprises a visual display which indicates variations in outflow through the episcleral aqueous outflow vessels within the plurality of regions of interest by displaying a composite image of each of the plurality of regions of interest, wherein the composite image includes a first indicator representing a centerline of each of the episcleral aqueous outflow vessel and a second indicator representing a border of each of the episcleral aqueous outflow vessel. 10. The method of claim 1 further comprising causing said glaucoma surgical treatment to be performed at the one or more target treatment areas identified on the basis of differences in flow of the liquid contrast agent through the plurality of regions of interest. 11. The method of claim 1 wherein the laser microendoscope is held stationary while imaging the episcleral aqueous outflow vessels within said plurality of regions of interest as those episcleral aqueous outflow vessels are perfused with the liquid contrast agent. 12. The method of claim 1 wherein the microendoscope is positioned between 0 and 3 millimeters behind a limbus of the eye.

Assignees

Inventors

Classifications

  • Methods or devices for eye surgery · CPC title

  • for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes · CPC title

  • A61B3/0025Primary

    characterised by electronic signal processing, e.g. eye models · CPC title

  • Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments (A61F9/008 takes precedence) · CPC title

  • Arrangements specially adapted for eye photography · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10993611B2 cover?
Methods and systems for assessing regional variations in aqueous outflow vessels of the eye and for optimizing locations within the eye stent implantation or other surgical procedures intended to increase aqueous outflow and reduce intraocular pressure.
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification A61B3/0025. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).